Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aurobindo Eyes Opportunities After Offloading Natrol For $550m
US-Based Nutritionals Firm To Be Sold After Six Years
Oct 29 2020
•
By
Dean Rudge
Aurobindo may eye further M&A with the cash derived from the sale of Natrol. • Source: Shutterstock
More from Deals
More from Business